Discovery research and clinical trials at the Simmons Cancer Institute at SIU provides the novel findings in cancer biology which will translate to better detection, treatment, and prevention options in the future. Research efforts are revealing fresh aspects in cellular and molecular mechanisms promoting tumor growth and metastases, new biomarkers for earlier detection and monitoring of therapeutic interventions, innovative agents and approaches for the treatment and prevention of cancer growth and proliferation. Simmons Cancer Institute research members performing these discovery-based

Finding Better Ways to Collaborate and Educate SIU School of Medicine TeleHealth and Video Services offers several options for easily collaborating and communicating across campus, throughout the state and around the world. We specialize in connecting you with your meeting or event through the use of cutting edge videoconferencing technology. Room-based Conferencing – Videoconferencing systems are installed in many rooms throughout the SIU Campuses. These collaboration spaces range from small sized rooms that host a few people to large auditoriums that can hold nearly 100 people. State of the

Patients who have been diagnosed with Stage II or III melanoma and have had surgery may be eligible to participate in a new clinical trial at Simmons Cancer Institute at Southern Illinois University School of Medicine. The clinical trial is studying the effectiveness of a vaccine for melanoma. Stephen Stone, M.D., professor of dermatology at SIU School of Medicine, is the principal investigator on the study. This Phase III melanoma clinical trial uses a combination of proteins associated with laboratory-grown melanoma cells to stimulate the body’s immune system to fight the cancer. The

NIH grant to fund researcher development, increase cancer research scope Research suggests that where you live in Illinois impacts your likelihood of dying from certain diseases, specifically cancer. Low-income, rural communities experience significant cancer health disparities, including lower screening rates, increased incidence, later stage at detection, poorer survival rates and higher mortality. A new National Institutes of Health grant will support a research partnership at the medical schools of Southern Illinois University and Washington University to further investigate the cancer

Aug. 26, 2015 - Southern Illinois University School of Medicine researcher Kathleen Campbell, PhD, professor in the Department of Surgery, has secured a five-year grant from the National Institutes of Health (NIH) to advance her decades of research in hearing loss prevention and treatment. The total budget for the project is $2.8 million. This grant will determine the optimal dosing level of D-methionine (D-met), a compound that has been shown to prevent hearing loss. D-met is an amino acid that has been found to protect against noise-induced hearing loss and ototoxicity, or damage to the ear

SIU Clinical Trial First to Study Use as Dietary Supplement in Ovarian Cancer Survivors A new clinical trial at Southern Illinois University School of Medicine is the first in the United States to examine the effects of flaxseed supplementation in women who have been diagnosed with ovarian cancer. Preliminary research suggests flaxseed can slow the growth of ovarian cancer cells. A number of clinical trials are focusing on the dietary benefits of flaxseed, which contains fiber, phytoestrogens (lignans) and omega-3 fatty acids. However, this clinical trial takes a different approach. It aims to

Simmons Cancer Institute at Southern Illinois University School of Medicine is hosting its 15th annual “Denim & Diamonds” fundraiser Saturday, October 3. The funds raised will support innovative research projects and enhance patient comforts. More than 90 percent of the funds raised at the event stay local. Guests at Denim & Diamonds are encouraged to dress in their finest denim or formal attire for the event, which will begin at 6:30 p.m. at the Crowne Plaza Hotel, 3000 S. Dirksen Parkway, Springfield. This year’s theme is “It’s a Wonderful Night for a Moondance.” Tickets are $125 per person